Skip to main content

Advertisement

Log in

Fatal thrombotic thrombocytopenic purpura as a rare complication following allogeneic stem cell transplantation

  • CASE REPORT
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

 Thrombotic thrombocytopenic purpura (TTP) is a rare disease which, together with hemolytic uremic syndrome, is subsumed under thrombotic microangiopathy. After stem cell transplantation (SCT), this syndrome represents a possibly fatal complication with a higher incidence in allogeneic SCT than in autologous SCT. Although plasmapheresis offers an encouraging treatment modality in classic TTP, this seems less effective in bone marrow transplant-associated microangiopathy. This is probably due to a different etiology. We present a case of transplant-associated TTP with a fatal outcome despite multiple courses of plasmapheresis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 11 November 1999 / Accepted: 23 February 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chemnitz, J., Fuchs, M., Blau, W. et al. Fatal thrombotic thrombocytopenic purpura as a rare complication following allogeneic stem cell transplantation. Ann Hematol 79, 527–529 (2000). https://doi.org/10.1007/s002770000187

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002770000187

Navigation